Close Menu

UC Berkeley

James Czaban, Frank Barone

Funding Update: Mar 31, 2009

Premium

Sequencing-Related NIH Funding, FY 2009, through March 26, 2009

Bruno Sobral, Michael Gilman, Kathy Gibson, Uwe Christians,Herbert Fritsche, Dan Crowther

The Quest For Function

Premium

Small RNA research continues to heat up as scientists deploy experimental and new computational tools to elucidate function. Plus, a peek at new findings in snoRNAs and moRs.

Already, the promise of synthetic biology is being realized as this level of engineering is brought into drug development. GT looks into synthetic biology drugs in the pipeline and where this field is heading.

In a talk at the AAAS meeting in Chicago, Stanford University bioengineer Drew Endy said that the US needs a national initiative to support and encourage synthetic biology.

Christian Johansson, Gov. Martin O'Malley, Ambrose Schwallie, Jonathan Fleming, Doug Cole, Jean George, Christopher Schaber, Paul Alivisatos, Steve Chu, President Barack Obama, Jay Keasling, Greg Kessler, Jeffrey New

Proteins, Front and Center

Premium

Once a tool that only piqued the interest of technology developers, protein microarrays have come into their own as scientists find new ways to apply them in basic and translational studies.

HINXTON, UK--The implications of the speedup of various genome projects was well reflected in this year’s Genome-Based Gene Structure Determination symposium, held June 1-2 on the Wellcome Trust Genome Campus

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.